Sublingual immunotherapy tablet containing recombinant Bet v1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sublingual immunotherapy tablet containing recombinant Bet v1, covering 2013-06-27 to 2013-06-27. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1 [Phase 1]